I don’t think VX-135 will ever get off the FDA clinical hold at 200mg; there’s just not enough margin for safety at that dose, as discussed in prior posts by jq1234 and me.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”